Cargando…
The Changing Face of Cystic Fibrosis and Its Implications for Screening
Early diagnosis, multidisciplinary care, and optimized and preventive treatments have changed the face of cystic fibrosis. Life expectancy has been expanded in the last decades. Formerly a pediatric disease, cystic fibrosis has reached adulthood. Mutation-specific treatments will expand treatment op...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570194/ https://www.ncbi.nlm.nih.gov/pubmed/33123635 http://dx.doi.org/10.3390/ijns6030054 |
_version_ | 1783596892851011584 |
---|---|
author | Naehrlich, Lutz |
author_facet | Naehrlich, Lutz |
author_sort | Naehrlich, Lutz |
collection | PubMed |
description | Early diagnosis, multidisciplinary care, and optimized and preventive treatments have changed the face of cystic fibrosis. Life expectancy has been expanded in the last decades. Formerly a pediatric disease, cystic fibrosis has reached adulthood. Mutation-specific treatments will expand treatment options and give hope for further improvement of quality of life and life expectancy. Newborn screening for CF fits perfectly into these care structures and offers the possibility of preventive treatment even before symptoms occur. Especially in countries without screening, newborn screening will fulfill that promise only with increased awareness and new care structures. |
format | Online Article Text |
id | pubmed-7570194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75701942020-10-28 The Changing Face of Cystic Fibrosis and Its Implications for Screening Naehrlich, Lutz Int J Neonatal Screen Review Early diagnosis, multidisciplinary care, and optimized and preventive treatments have changed the face of cystic fibrosis. Life expectancy has been expanded in the last decades. Formerly a pediatric disease, cystic fibrosis has reached adulthood. Mutation-specific treatments will expand treatment options and give hope for further improvement of quality of life and life expectancy. Newborn screening for CF fits perfectly into these care structures and offers the possibility of preventive treatment even before symptoms occur. Especially in countries without screening, newborn screening will fulfill that promise only with increased awareness and new care structures. MDPI 2020-07-03 /pmc/articles/PMC7570194/ /pubmed/33123635 http://dx.doi.org/10.3390/ijns6030054 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Naehrlich, Lutz The Changing Face of Cystic Fibrosis and Its Implications for Screening |
title | The Changing Face of Cystic Fibrosis and Its Implications for Screening |
title_full | The Changing Face of Cystic Fibrosis and Its Implications for Screening |
title_fullStr | The Changing Face of Cystic Fibrosis and Its Implications for Screening |
title_full_unstemmed | The Changing Face of Cystic Fibrosis and Its Implications for Screening |
title_short | The Changing Face of Cystic Fibrosis and Its Implications for Screening |
title_sort | changing face of cystic fibrosis and its implications for screening |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570194/ https://www.ncbi.nlm.nih.gov/pubmed/33123635 http://dx.doi.org/10.3390/ijns6030054 |
work_keys_str_mv | AT naehrlichlutz thechangingfaceofcysticfibrosisanditsimplicationsforscreening AT naehrlichlutz changingfaceofcysticfibrosisanditsimplicationsforscreening |